Agomelatine 阿戈美拉汀
CAS 138112-76-2 MFCD00916659
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} A-AM, Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Biochemicals and Reagents, Cell Biology, Cell Signaling and Neuroscience, GPCR Modulators, GPCR Proteins, Modulators and Antibodies, Meatonin - Receptor Agonists, Melatonins, Membrane Protein Biology Tools, Neurobiology, Neuroscience, Pharmacologicals, Proteins and Derivatives, Servier
- {SNA} A-AM, Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, GPCR Modulators, GPCR Proteins, Modulators and Antibodies, Meatonin - Receptor Agonists, Melatonins, Membrane Protein Biology Tools,
产品应用
- ########
相关文献及参考
- Yous, S., et al.: J. Med. Chem., 35, 1484 (1992),
- Zhdanova, I., et al.: J. Clin. Endocrinol. Metab., 86, 4727 (2001),
- Cajochen, C., et al.: J. Pineal Res., 35, 149 (2003),
安全信息
GHS Symbol
- P273 Avoid release to the environment. 避免释放到环境中。
- H400 Verytoxictoaquaticlife 对水生生物毒性非常大。
- S61 Avoid release to the environment. Refer to special instructions/safety data sheet 避免释放到环境中,参考特别指示/安全收据说明书;
- R50 Very toxic to aquatic organisms 对水生生物极毒
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >1 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #5318994